生体触媒作用および生体触媒の世界市場2023-2030

世界の生体触媒作用および生体触媒市場は予測期間中にCAGR 6.9%で成長すると予測されます。生体触媒と生体触媒市場の成長は、主にバイオ医薬品と地域全体の食品製造市場の需要の増加によるバイオ医薬品産業の急速な拡大によって増加しています。酵素へのアクセスが容易になり、工業プロセスの要件を満たすためにそれらの酵素を変更する能力があるため、バイオ医薬品事業における生体触媒の使用は収益性の高い速度で成長しています。生物触媒は現在、抗生物質、スタチン、エナンチオマー的に純粋なビルディング・ブロックなどの医薬品やその中間体の製造に使用されています。欧州製薬団体連合会（EFPIA）によると、米国、欧州、日本の市場は2016年から2021年の間にそれぞれ64.4%、16.8%、6.0%を占めています。2022年、オーストラリア政府は、2022-23年に1,320億米ドル、2025-26年に1,400億米ドルを投資し、今後4年間で総額5,370億米ドルを投入する「保健医療産業成長計画」を発表し、オーストラリアにおけるより良い医療の新時代を推進しています。

セグメント別の展望

生体触媒作用および生体触媒の世界市場では、バイオ医薬品のサブセグメントが大きなシェアを占めると予想されます。

用途別では、バイオ医薬品サブセグメントが世界の生体触媒作用および生体触媒市場で大きなシェアを占めると予想されています。バイオ医薬品産業の収益は、医薬品製造に使用される薬剤の急速な需要により年々増加しています。過去数年間、中国の製薬業界は成長率でトップでした。医薬品の消費は、臨床習慣の変化や慢性疾患・高齢化問題の増加により増加しています。また、インド、中国、ブラジルなどの新興諸国でも、COVID-19亜種の出現、生活習慣病、高齢化などにより、医薬品の需要が増加しています。生体触媒は、このような病気を治療する抗生物質の製造工程で使用されます。そして、生体触媒の市場は、世界の医薬品セクターとともに拡大しています。主に医薬品や食品製造業への需要の高まりによってバイオ医薬品産業が急成長していることが、生体触媒作用および生体触媒の市場成長の主な要因となっています。酵素へのアクセスが容易になり、工業プロセスの要件を満たすためにそれらの酵素を変更する能力があるため、製薬事業における生体触媒の使用は収益性の高い速度で成長しています。生物触媒は現在、抗生物質、スタチン、エナンチオマー的に純粋なビルディング・ブロックなどの医薬品やその中間体の生産に使われています。2022年4月、成人の便秘を伴う過敏性腸症候群（IBS-C）治療薬IBSRELA NHE3阻害薬がアーデリクスから発売されました。米国食品医薬品局（FDA）から承認を受けた最初の製品はIBSRELAです。

地域別展望

北米地域が世界の生体触媒作用および生体触媒市場で最も急成長する見込み

全地域の中で、北米地域が予測期間中に最も急成長する地域市場になると予想されます。この地域は、チーズ、ビネガー、ワインの生産、パンのリーブン化、ビールの醸造など、食品加工を助けるために生体触媒が広く採用されているアプリケーションの数により、大きな成長が見込まれています。これらのプロセスにおいて、酵素はエネルギーと資源の節約に役立つだけでなく、全体的な効率を向上させる。米国農務省によると、米国では、農業部門は、農業ビジネスを含みます。米国農務省によると、農業部門は農業ビジネスを拡大し、さまざまな農業関連産業を含みます。2021年、農業・食品・関連産業は米国の国内総生産の5.4%に寄与し、米国雇用の10.5%を供給しています。米国人の食費は家計の平均12%に達します。このように、飲食品産業の増加に伴い、同国における生体触媒と生体触媒の需要も増加し、予測期間中に北米の生体触媒と生体触媒市場をさらに牽引すると予想されます。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 生体触媒作用および生体触媒の世界市場：タイプ別
  • ヒドロラーゼ
  • 酸化還元酵素
  • 転移酵素
  • その他
• 生体触媒作用および生体触媒の世界市場：用途別
  • 飲食品
  • バイオ燃料生産
  • 農業と飼料
  • バイオ医薬品
  • 洗浄剤
  • その他

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• AB Enzymes
• Afton Chemical
• Amano Enzyme Inc.
• Arzeda Corporation
• BASF SE
• Chr Hansen Holding A/S
• Codexis Inc.
• Debut Biotechnology, Inc.
• DSM
• DuPont de Nemours, Inc.
• Dyadic International, Inc.
• EnginZyme AB
• Ingenza
• Lonza Group Ltd.
• Novozymes
• Piramal Enterprises Ltd.
• RP Management LLC
• Soufflet Agro Rus, LLC
• Unilever PLC
• Zymtronix Catalytic Systems Inc.

LIST OF TABLES

• 1. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL HYDROLASES BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL OXIDOREDUCTASES BIOCATALYSIS AND MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL TRANSFERASES BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL OTHERS BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 7. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET IN FOOD AND BEVERAGES, MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN CLEANING AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN BIOFUEL PRODUCTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN AGRICULTURE AND FEED MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN BIOPHARMACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. NORTH AMERICAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 15. NORTH AMERICAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 16. NORTH AMERICAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 17. EUROPEAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 18. EUROPEAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 19. EUROPEAN BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 20. ASIA-PACIFIC BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 21. ASIA-PACIFIC BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 22. ASIA-PACIFIC BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 23. REST OF THE WORLD BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 24. REST OF THE WORLD BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 25. REST OF THE WORLD BIOCATALYSIS AND BIOCATALYSTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
• 2. GLOBAL HYDROLASES BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL OXIDOREDUCTASES BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE ANALYSIS BY REGION, 2021-2028 (%)
• 4. GLOBAL TRANSFERASES BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL OTHERS BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 7. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET IN FOOD AND BEVERAGES, MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN CLEANING AGENTS MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN BIOFUEL PRODUCTION MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN AGRICULTURE AND FEED MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN BIOPHARMACEUTICALS MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL BIOCATALYSIS AND BIOCATALYSTS IN OTHERS MARKET SHARE ANALYSIS BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL OTHER TECHNOLOGIES IN BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL BIOCATALYSIS AND BIOCATALYSTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. US BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 16. CANADA BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 17. UK BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 18. FRANCE BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 19. GERMANY BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 20. ITALY BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 21. SPAIN BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 22. REST OF EUROPE BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 23. INDIA BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 24. CHINA BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 25. JAPAN BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 26. SOUTH KOREA BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 27. REST OF ASIA-PACIFIC BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)
• 28. REST OF THE WORLD BIOCATALYSIS AND BIOCATALYSTS MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Biocatalysis and Biocatalysts Market Size, Share and Trends Analysis Report by Type (Hydrolases, Oxidoreductases, Transferases, Others) and by Application (Food and Beverages, Cleaning Agents, Biofuel Production, Agriculture and Feed, Biopharmaceuticals and Others) Forecast Period (2023-2030).

The global biocatalysis and biocatalysts market is anticipated to grow at a CAGR of 6.9% during the forecast period. The biocatalysis and biocatalysts market growth is increasing by the rapid expansion of the biopharmaceutical industry mainly due to the increasing demand for biopharmaceuticals and food manufacturing market across the region. Due to easier access to enzymes and the capacity to modify those enzymes to satisfy the requirements of industrial processes, the use of biocatalysis in the biopharmaceutical business is growing at a profitable rate. Biocatalysts are currently used in the production of pharmaceuticals or their intermediates such as antibiotics, statins, and enantiomerically pure building blocks, and other. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the US, European and Japan markets held 64.4%, 16.8%, and 6.0% respectively during the period 2016-2021. In 2022, the Australian government announced it would invest $132 billion in 2022-23, increasing to $140 billion in 2025-26, with a total commitment of $537 billion over the next four years in the Health and Medical Industry Growth Plan to drive a new era of better health care in Australia.

Segmental Outlook

The global biocatalysis and biocatalysts market is segmented based on the type, and application. Based on the type, the market is segmented into hydrolases, oxidoreductases, transferases and others. Based on the application, the market is sub-segmented into food and beverages, cleaning agents, biofuel production, agriculture and feed, biopharmaceuticals and others. Among the type, the hydrolases sub-segment is anticipated to hold a considerable share of the market, due to the increase in utilization of hydrolases in starch processing and the biofuel industry for saccharification and starch liquefaction.

The Biopharmaceuticals Sub-Segment is Anticipated to Hold Prominent Share in the Global Biocatalysis and Biocatalysts Market

Among the application, the biopharmaceuticals sub-segment is expected to hold a prominent share of the global biocatalysis and biocatalysts market across the globe. The biopharmaceutical industry's revenue is increasing yearly due to rapid demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of COVID-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And the market for biocatalysts is expanding along with the global pharmaceutical sector. The rapid growth of the biopharmaceutical industry, which is primarily driven by rising demand for pharmaceuticals and food Manufacturer industries, is a major driver of the market growth for biocatalysis and biocatalysts. Due to easier access to enzymes and the capacity to modify those enzymes to satisfy the requirements of industrial processes, the use of biocatalysis in the pharmaceutical business is growing at a profitable rate. Biocatalysts are currently in the production of pharmaceuticals or their intermediates such as antibiotics, statins, and enantiomerically pure building blocks, and more. In April 2022, IBSRELA NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by Ardelyx. The first Ardelyx product receive approval from the US Food and Drug Administration is IBSRELA.

Regional Outlook

The global biocatalysis and biocatalysts market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, the Europe region is projected to experience considerable growth in the biocatalysis and biocatalysts market. This may be as a result of the strict policy laws in a number of European nations to increase the use of sustainable raw materials instead of fossil fuels and lower greenhouse gas (GHG) emissions. Global Insurtech Market Growth, by Region 2023-2030

Source: OMR Analysis

The North America Region is Expected to Hold Fastest Growing Share in the Global Biocatalysis And Biocatalysts Market

Among all regions, the North America region is anticipated to emerge as the fastest-growing regional market over the forecast period. The region is expected to witness significant growth due number of applications, such as the production of cheese, vinegar, and wine, the leavening of bread, the brewing of beer, and others, biocatalyst is widely employed to help with food processing. In these processes, enzymes help to save energy and resources, as well as improve the overall efficiency. According to the US Department of Agriculture, US. Agriculture sector extends the farm business to include a range of farm-related industries. In 2021, agriculture, food, and related industries contributed 5.4% to US gross domestic product and provided 10.5% of U.S. employment; Americans' expenditures on food amount to 12% of household budgets on average. Thus, with the rising food and beverage industry, the demand for biocatalysis and biocatalysts in the country will also increase, which is anticipated to further drive the biocatalysis and biocatalysts market in North America during the forecast period.

Market Players Outlook

The major companies serving the global biocatalysis and biocatalysts market include Unilever PLC, EnginZyme AB, Arzeda Corporation, Ingenza, Zymtronix Catalytic Systems Inc, Debut Biotechnology, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, and product launches, to stay competitive in the market. For instance, in October 2022, Ginkgo Bioworks partnered with Merck to use engineered enzymes as biocatalysts for Merck's active pharmaceutical ingredient manufacturing programs.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global biocatalysis and biocatalysts market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight AND Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Biocatalysis and Biocatalysts Market by Type
  • 4.1.1. Hydrolases
  • 4.1.2. Oxidoreductases
  • 4.1.3. Transferases
  • 4.1.4. Others
• 4.2. Global Biocatalysis and Biocatalysts Market by Application
  • 4.2.1. Food and Beverages
  • 4.2.2. Biofuel Production
  • 4.2.3. Agriculture and Feed
  • 4.2.4. Biopharmaceuticals
  • 4.2.5. Cleaning Agents
  • 4.2.6. Others

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. AB Enzymes
• 6.2. Afton Chemical
• 6.3. Amano Enzyme Inc.
• 6.4. Arzeda Corporation
• 6.5. BASF SE
• 6.6. Chr Hansen Holding A/S
• 6.7. Codexis Inc.
• 6.8. Debut Biotechnology, Inc.
• 6.9. DSM
• 6.10. DuPont de Nemours, Inc.
• 6.11. Dyadic International, Inc.
• 6.12. EnginZyme AB
• 6.13. Ingenza
• 6.14. Lonza Group Ltd.
• 6.15. Novozymes
• 6.16. Piramal Enterprises Ltd.
• 6.17. RP Management LLC
• 6.18. Soufflet Agro Rus, LLC
• 6.19. Unilever PLC
• 6.20. Zymtronix Catalytic Systems Inc.